Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed Combination Latanoprost-Timolol vs Components in Glaucoma/OHT
NCT00800267Phase 3Completed
- Sponsor
- Viatris
- Start
- Jul 1997
- Primary completion
- Jun 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of latanoprost + timolol in Glaucoma, ocular hypertension, sponsored by Viatris. Started Jul 1997; status: completed.
02
Drugs
latanoprost + timolol
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00800267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00800267.